Devyser wins tender in Italy worth approximately SEK 5.7 million – doubling test volumes compared with previous agreement
Devyser Diagnostics AB, through its Italian subsidiary, has been awarded a renewed tender by...
News | May 30, 2020
From June 1st to June 7th 2020 is World Haemochromatosis Week.
Hemochromatosis is characterised by an excess of iron in blood. Causes for the disease are mostly hereditary and the illness can be diagnosed by genetic testing. Hemochromatosis is often overlooked because its symptoms are generally non-specific and can be confused with other illnesses.
The excess iron deposited in a variety of organs can however lead to irreversible tissue damage, particularly in the liver and pancreas, which leads to serious diseases such as cirrhosis, diabetes, arthritis or hypogonadism.
Early diagnosis of the disease is thus crucial.
The single tube PCR reagent kit Devyser HFE allows a fast and specific detection of mutations in the HFE gene.
Devyser Diagnostics AB, through its Italian subsidiary, has been awarded a renewed tender by...
Read More
Devyser announced that One Lambda™ Devyser Accept cfDNA, its test for monitoring kidney transplant...
Read More
Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial...
Read More
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
Read More